Prostatype Genomics issues 118,378,642 TO6 warrants, 236,757,284 TO7 warrants in rights issue

• Prostatype Genomics rights issue issued 118,378,642 TO6 warrants, exercisable Sept. 1–15 at SEK 0.1 per share.
• Full TO6 exercise could raise about SEK 11.8 million; last trading day expected Sept. 11.
• Issued 236,757,284 TO7 warrants; exercise window tied to Medicare reimbursement approval, no earlier than Sept. 1 and no later than Dec. 7.
• TO7 strike set at 70% of 10-day VWAP, capped at SEK 0.2 and floored at SEK 0.1; full exercise could raise about SEK 47.4 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Prostatype Genomics AB published the original content used to generate this news brief on July 27, 2026, and is solely responsible for the information contained therein.